Study Reveals Impact of Artificial Sweeteners on Gut Bacteria Growth
Researchers estimate that approximately 75% of processed foods contain commercially used sweeteners, which encompass both artificial and natural sweeteners, as well as sugar alcohols. Previous studies have linked the consumption of artificial sweeteners to various health concerns, including an increased risk of heart disease, stroke, type 2 diabetes, metabolic syndrome, cognitive decline, chronic kidney disease, and cancer. Additionally, earlier research has suggested a negative impact of artificial sweeteners on the gut microbiome.
A new study published in the journal Molecular Systems Biology has found that certain commercially used sweeteners can slow or halt the growth of beneficial gut bacteria, either independently or through enhanced effects when combined with specific drugs. In this study, researchers utilized an in vitro model to grow 25 different gut bacterial species in a laboratory setting. These species included beneficial, harmful, and neutral bacteria. Each species was exposed to 39 common sweeteners, which included both artificial and natural varieties.
Kiran Raosaheb Patil, PhD, a professor of molecular systems biology at the MRC Toxicology Unit at the University of Cambridge and co-lead author of the study, emphasized the importance of understanding the molecular mechanisms by which sweeteners may influence physiological processes. He stated, "Previous studies and World Health Organization (WHO) guidance have shown links between sweeteners and health parameters. It is therefore important to investigate molecular mechanisms through which the sweeteners may be affecting physiological processes. Such molecular insights can guide better-informed decisions for sweetener usage."
The study's findings revealed that about 75% of the tested sweeteners altered the growth of at least one gut bacterial species. Patil noted, "We tested sweeteners and related compounds to assess which, if any, can impact gut bacterial growth. Our laboratory tests show that many sweetener compounds have the potential to alter the growth of certain gut bacteria. While we yet do not know how these results would translate in a human context, our results suggest that future cohort studies should consider the direct effect on growth and metabolism of gut bacteria."
In addition to testing sweeteners alone, researchers also examined their effects in combination with common food compounds such as caffeine and vanillin, as well as eight frequently used medications. They identified over 100 interactions between these combinations. Notably, the combination of isosteviol—a compound derived from stevia—and the antidepressant duloxetine was found to suppress two gut bacteria that are crucial for maintaining a healthy digestive system.
Patil clarified that isosteviol is a sweetener derivative and was included in the study to broaden the mechanistic scope from a chemical perspective. The study also included other stevia sweeteners and highlighted that these compounds exhibited synergistic interactions with duloxetine. He remarked, "Our data highlights that sweeteners may interact with medications, and such 'mixture effects' should be investigated in future clinical studies. These effects may not necessarily be harmful, but for now we simply do not know."
Ashkan Farhadi, MD, a board-certified gastroenterologist who was not involved in the study, praised its comprehensiveness, noting that it not only assessed the effects of sweeteners on the microbiome but also considered the interactions with other food ingredients and medications. He stated, "This study is an in vitro study on bacterial culture, and we need to have similar studies in an animal model or, even better, in humans to see if artificial sweeteners can adversely affect the growth or proliferation of good germs in the human gut, so we have more direct evidence to provide recommendations."
For those looking to reduce their intake of commercially used sweeteners, Monique Richard, MS, RDN, LDN, a registered dietitian nutritionist, suggests a gradual approach to retrain the palate while increasing awareness of dietary choices. She emphasizes that small, sustainable changes can lead to better long-term habits. Richard advises focusing on increasing the variety of whole foods in the diet, which can naturally reduce sweetener consumption over time.
Overall, this study underscores the complex interactions between artificial sweeteners, gut bacteria, and medications, highlighting the need for further research to understand the implications for human health.




